Medical Research News

RSS

American Heart Association honors UVA professor for contributions to cardiovascular research

Robert M. Carey, MD, Professor of Medicine at the University of Virginia School of Medicine, has been named a Distinguished Scientist of the American Heart Association for his "extraordinary contributions" to cardiovascular research.

8 Sep 2020

Microglia-targeting nanotherapeutics for treatment of neurodegenerative disorders

Inspired by the need for new and better therapies for neurodegenerative diseases, such as Parkinson's disease and Alzheimer's disease, Rutgers University researchers are exploring the link between uncontrolled inflammation within the brain and the brain's immune cells, known as microglia.

8 Sep 2020

Scientists discover tissue reparative role for a rare immune cell type in the gut

Scientists from King's College London have discovered an unexpected tissue reparative role for a rare immune cell type in the gut that could tip toward fibrosis or cancer if dysregulated.

8 Sep 2020

Research highlights the effects of confinement due to COVID-19 among pregnant women

Researchers of Medicine and Physical Therapy at the CEU Cardenal Herrera University of Valencia and of the Italian University of Catania, have published the results of the first study on the effects of confinement due to the COVID-19 pandemic among pregnant Spanish women.

8 Sep 2020

Blanket approach to prescribing medication during pregnancy may put low birth weight babies at risk

New research led by the University of South Australia shows that a blanket approach to prescribing medication during pregnancy may put low birth weight babies at risk for the rest of their lives.

8 Sep 2020

Ghrelin may help protect the elderly population from muscle loss

The hormone, ghrelin, may help protect the elderly population from muscle loss, according to a study being presented at e-ECE 2020. The study found that administering a particular form of ghrelin to older mice helped to restore muscle mass and strength.

8 Sep 2020

Study addresses the role of macrophage activation syndrome in COVID-19

Scientists review macrophage activation syndrome — a feature of the cytokine storm that kills patients with severe cases of COVID-19, as well as possible treatments.

8 Sep 2020

Personalized determination of genetic factors may improve treatment for polycythaemia vera

Polycythaemia vera is a chronic malignant disease of the haematopoietic system and is treated with interferon-alpha-based drugs, in most cases with long-lasting success. However, in some cases this therapy is unsuccessful for reasons that are not yet understood.

8 Sep 2020

COVID-19 lockdown has not reduced the level of toxic fine particles in Scotland

The significant reduction in vehicle journeys during the COVID-19 lockdown did not reduce the level of toxic fine particles in Scotland's air, according to experts at the University of Stirling.

8 Sep 2020

Focal high-intensity focused ultrasound ablation is an effective treatment for prostate cancer

For some prostate cancer patients, radical treatment (surgery or radiation) are treatment standards. However, these procedures may cause side effects including urinary incontinence or impotency.

8 Sep 2020

Research suggests school reopenings contribute to rise in COVID-19 cases

A study recently published on the preprint server medRxiv in September 2020 by researcher Richard Beesley at Juvenile Arthritis Research reports on the impact of school reopenings on the spread of the virus.

8 Sep 2020

Fight for Sight partners with Diabetes UK to investigate link between eye disease and COVID-19

Eye research charity Fight for Sight is partnering with Diabetes UK to investigate if people with the eye disease diabetic retinopathy are at greater risk of developing complications from Covid-19, in a study that hopes to save lives.

8 Sep 2020

Study links brain astrocyte dysfunction to Parkinson’s disease pathology

A new study using induced pluripotent stem cell technology links astrocyte dysfunction to Parkinson’s disease pathology.

8 Sep 2020

Limited gut inflammation in COVID-19

A new study by researchers at the Icahn School of Medicine at Mount Sinai and published on the preprint server medRxiv in September 2020 shows that gut infection with this virus produces primarily mucosal immunity but also a limited inflammatory response.

8 Sep 2020

Study finds strong T cell responses in patients recovered from COVID-19

Oxford University researchers have found that natural infection with COVID-19 produces a robust T cell response, including inducing T cell ‘memory’ to potentially fight future infections.

8 Sep 2020

Researchers develop simple tool to assess impaired consciousness in clinical setting

The University of Glasgow's Sir Graham Teasdale, co-creator of the Glasgow Coma Scale, once again has teamed with Paul M. Brennan and Gordon D. Murray of the University of Edinburgh.

8 Sep 2020

Antibody-mediated platelet death linked to COVID-19 severity

A new study by University of Tuebingen researchers shows the strong association between platelet apoptosis and the thrombotic manifestations that may underlie critical COVID-19 illness.

7 Sep 2020

Vitamin D levels in the blood may be a better predictor of future health and disease risks

Free, circulating vitamin D levels in the blood may be a better predictor of future health risks in aging men, according to a study being presented at e-ECE 2020.

7 Sep 2020

Scientists describe various dynamic structures of the SARS-CoV-2 spike protein

Early in the pandemic, scientists uncovered the role of the ACE2 receptor in SARS-CoV-2, the virus that causes the coronavirus disease (COVID-19). The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein and the angiotensin-converting enzyme 2 (ACE2) receptors act as a lock and key for cell infection.

7 Sep 2020

Novel markers may predict patient response to immune checkpoint inhibitors

For many individuals with different types of cancer, immune checkpoint inhibitors can effectively boost their immune system to fight their disease, but not all patients benefit from these medications.

7 Sep 2020

Medical Research News

American Heart Association honors UVA professor for contributions to cardiovascular research

Microglia-targeting nanotherapeutics for treatment of neurodegenerative disorders

Scientists discover tissue reparative role for a rare immune cell type in the gut

Research highlights the effects of confinement due to COVID-19 among pregnant women

Blanket approach to prescribing medication during pregnancy may put low birth weight babies at risk

Ghrelin may help protect the elderly population from muscle loss

Study addresses the role of macrophage activation syndrome in COVID-19

Personalized determination of genetic factors may improve treatment for polycythaemia vera

COVID-19 lockdown has not reduced the level of toxic fine particles in Scotland

Focal high-intensity focused ultrasound ablation is an effective treatment for prostate cancer

Research suggests school reopenings contribute to rise in COVID-19 cases

Fight for Sight partners with Diabetes UK to investigate link between eye disease and COVID-19

Study links brain astrocyte dysfunction to Parkinson’s disease pathology

Limited gut inflammation in COVID-19

Study finds strong T cell responses in patients recovered from COVID-19

Researchers develop simple tool to assess impaired consciousness in clinical setting

Antibody-mediated platelet death linked to COVID-19 severity

Vitamin D levels in the blood may be a better predictor of future health and disease risks

Scientists describe various dynamic structures of the SARS-CoV-2 spike protein

Novel markers may predict patient response to immune checkpoint inhibitors

Advancing Menopause Care: Non-Hormonal Treatments for Vasomotor Symptoms

Building quality into drug development for safer, faster medicines

How Pulp Fixin Is Turning Paper into High-Performance Sustainable Labware

Latest News